Residual intraretinal retinoblastoma after chemoreduction failure.
作者信息
Hwang Christopher K, Aaberg Thomas M, Chevez-Barrios Patricia, Verner-Cole Elizabeth, Gombos Dan S, Paysse Evelyn, Chintagumpala Murali, Gao Weiqing, Grossniklaus Hans E
机构信息
Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322, USA.
出版信息
Arch Ophthalmol. 2012 Feb;130(2):246-8. doi: 10.1001/archopthalmol.2011.1588.
Abstract
摘要
相似文献
1
Residual intraretinal retinoblastoma after chemoreduction failure.化疗减灭失败后残留的视网膜内视网膜母细胞瘤
Arch Ophthalmol. 2012 Feb;130(2):246-8. doi: 10.1001/archopthalmol.2011.1588.
2
Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.仅接受化疗减积治疗的视网膜母细胞瘤患者眼部的组织病理学发现
Arch Ophthalmol. 2003 Aug;121(8):1125-31. doi: 10.1001/archopht.121.8.1125.
3
Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.针对隐匿于致密白内障后的不可见视网膜母细胞瘤的化学减容治疗。
Can J Ophthalmol. 2010 Oct;45(5):539-40. doi: 10.3129/i10-025.
4
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.视网膜母细胞瘤中化学减灭术失败的原因及导致最终采用外照射放疗和眼球摘除术治疗的相关因素分析。
Ophthalmology. 2004 Oct;111(10):1917-24. doi: 10.1016/j.ophtha.2004.04.016.
5
Chemoreduction for unilateral retinoblastoma.单侧视网膜母细胞瘤的化学减灭法
Arch Ophthalmol. 2002 Dec;120(12):1653-8. doi: 10.1001/archopht.120.12.1653.
6
Clinical result of prolonged primary chemotherapy in retinoblastoma patients.视网膜母细胞瘤患者长期初级化疗的临床结果
Korean J Ophthalmol. 2003 Jun;17(1):35-43. doi: 10.3341/kjo.2003.17.1.35.
7
Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.106例连续患者的162只眼在接受6个周期的视网膜母细胞瘤化疗减瘤后出现新发视网膜母细胞瘤。
Arch Ophthalmol. 2003 Nov;121(11):1571-6. doi: 10.1001/archopht.121.11.1571.
8
Histopathologic changes in retinoblastoma after chemoreduction.化学减容后视网膜母细胞瘤的组织病理学变化
Retina. 2000;20(1):33-6. doi: 10.1097/00006982-200001000-00006.
9
Treatment of intraocular retinoblastoma with vincristine and carboplatin.用长春新碱和卡铂治疗眼内视网膜母细胞瘤。
J Clin Oncol. 2003 May 15;21(10):2019-25. doi: 10.1200/JCO.2003.09.103.
10
Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.眼内视网膜母细胞瘤的联合化学减灭术及辅助治疗
Ophthalmology. 1997 Dec;104(12):2101-11. doi: 10.1016/s0161-6420(97)30053-0.
引用本文的文献
1
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.视网膜母细胞瘤。五十年的进展。第七十一届爱德华·杰克逊纪念讲座。
Am J Ophthalmol. 2014 Nov;158(5):875-91. doi: 10.1016/j.ajo.2014.07.025. Epub 2014 Jul 24.
本文引用的文献
1
Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.双侧视网膜母细胞瘤初次化疗失败后挽救性外照射放疗：眼球和视力保留率
Br J Ophthalmol. 2009 Jul;93(7):891-4. doi: 10.1136/bjo.2007.129981. Epub 2009 Mar 26.
2
Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes.连续34只眼的弥漫浸润性视网膜母细胞瘤的临床谱系
Ophthalmology. 2008 Dec;115(12):2253-8. doi: 10.1016/j.ophtha.2008.07.003. Epub 2008 Oct 29.
3
Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.视网膜母细胞瘤肿瘤中的血管成熟：新生血管和成熟血管的空间分布及其对眼部治疗的影响。
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1020-4. doi: 10.1167/iovs.08-2654. Epub 2008 Oct 24.
4
Cancer stem cell characteristics in retinoblastoma.视网膜母细胞瘤中的癌症干细胞特征
Mol Vis. 2005 Sep 12;11:729-37.
5
Intraocular retinoblastoma presenting as ocular and orbital inflammation.表现为眼部和眼眶炎症的眼内视网膜母细胞瘤。
Int Ophthalmol Clin. 1996 Winter;36(1):153-60. doi: 10.1097/00004397-199603610-00016.
6
Angiogenesis capacity as a diagnostic marker for human eye tumors.血管生成能力作为人眼肿瘤的诊断标志物。
Surgery. 1979 Jul;86(1):36-40.
Zotero 插件